HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use CAVERJECT IMPULSE safely and effectively. See full prescribing information for CAVERJECT IMPULSE.
CAVERJECT IMPULSE® (alprostadil) for injection, for intracavernosal use
Initial U.S. Approval: 1981
INDICATIONS AND USAGE
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
For injection: 10 mcg or 20 mcg freeze-dried powder for reconstitution in a dual-chamber syringe (3).
WARNINGS AND PRECAUTIONS
Most common (≥10%) adverse reactions: penile pain (6.1).
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.